Lingye Zhang
Papers
1
Total Citations
30
H-Index
1
About
Lingye Zhang is a leading researcher in rehabilitation robotics and neurorehabilitation, with a primary focus on developing and validating robotic systems for locomotor recovery in stroke patients. Their most notable contribution is the design and clinical evaluation of the BEAR-H1, a novel lower-limb exoskeletal robot aimed at restoring walking function in subacute stroke survivors. Zhang’s landmark 2021 multi-center, non-inferiority randomized controlled trial, which has garnered 30 citations, demonstrated that the BEAR-H1 is as effective as conventional therapy in improving locomotor outcomes, while also offering enhanced safety and patient engagement. This work bridges the gap between engineering innovation and evidence-based clinical practice, providing a scalable solution for rehabilitation centers. Zhang’s research has been instrumental in advancing robot-assisted therapy as a viable alternative to traditional physiotherapy, with implications for reducing therapist burden and accelerating recovery timelines. Their achievements include securing ethical approval from the First Affiliated Hospital of Nanjing Medical University, underscoring their commitment to rigorous clinical validation. For students and researchers, Zhang’s work exemplifies how interdisciplinary collaboration can translate cutting-edge robotics into tangible patient benefits.
Research Focus
Key Achievements
Top Papers
- 1